Pfizer registers four studies: elranatamab, berobenatide, tilrekimig, and completed etrasimod trialOct 23Weekly roundup, 14 itemsabrocitinibatirmociclibUpdated
FDA lifts clinical hold on Arbutus's AB-101 IND applicationOct 22Regulatory decisionArbutus Biopharma Corplinezolid
Zydus Pharms gets three FDA supplement approvals in one week for generic drugsJul 29Weekly roundup, 2 itemsZydus Lifesciences